SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
11-Feb-22 6:06 PM View: | Eli Lilly & Co. (LLY) | 09-Feb-22 | Grant | 12,339 | $243.27 | $3,001,710.00 | 9% 140.47K to 152.81K | 7% |
03-Feb-22 4:55 PM View: | Eli Lilly & Co. (LLY) | 01-Feb-22 | Payment of Exercise | 4,554 | $245.39 | $1,117,510.00 | (3%) 145.03K to 140.47K | |
03-Feb-22 4:55 PM View: | Eli Lilly & Co. (LLY) | 01-Feb-22 | Option Exercise | 10,170 | -- | -- | 8% 134.86K to 145.03K | |
10-Feb-21 8:31 PM View: | Eli Lilly & Co. (LLY) | 08-Feb-21 | Grant | 26,133 | $205.77 | $5,377,390.00 | 24% 108.72K to 134.85K | (2%) |
03-Feb-21 6:33 PM View: | Eli Lilly & Co. (LLY) | 01-Feb-21 | Payment of Exercise | 6,746 | $207.97 | $1,402,970.00 | (6%) 115.47K to 108.72K | |
03-Feb-21 6:33 PM View: | Eli Lilly & Co. (LLY) | 01-Feb-21 | Option Exercise | 15,078 | -- | -- | 15% 100.39K to 115.47K | |
18-Aug-20 3:31 PM View: | Eli Lilly & Co. (LLY) | 17-Aug-20 | Market Sale (Planned) | 7,204 | $150.64 | $1,085,210.00 | (7%) 107.59K to 100.39K | (10%) |
31-Mar-20 11:50 AM View: | Eli Lilly & Co. (LLY) | 30-Mar-20 | Market Sale (Planned) | 14,657 | $134.30 | $1,968,430.00 | (12%) 122.25K to 107.59K | (22%) |
13-Feb-20 5:36 PM View: | Eli Lilly & Co. (LLY) | 11-Feb-20 | Grant | 14,657 | $144.25 | $2,114,270.00 | 14% 107.59K to 122.25K | 13% |
04-Feb-20 3:47 PM View: | Eli Lilly & Co. (LLY) | 01-Feb-20 | Payment of Exercise | 5,851 | $139.64 | $817,034.00 | (5%) 113.44K to 107.59K | (17%) |
04-Feb-20 3:47 PM View: | Eli Lilly & Co. (LLY) | 01-Feb-20 | Option Exercise | 13,055 | -- | -- | 13% 100.39K to 113.44K | |
09-Sep-19 12:12 PM View: | Eli Lilly & Co. (LLY) | 05-Sep-19 | Market Sale (Planned) | 9,452 | $115.00 | $1,086,980.00 | (9%) 109.66K to 100.21K | (41%) |
13-Mar-19 12:47 PM View: | Eli Lilly & Co. (LLY) | 12-Mar-19 | Market Sale (Planned) | 14,847 | $123.16 | $1,828,560.00 | (12%) 124.68K to 109.83K | (30%) |
06-Feb-19 7:10 PM View: | Eli Lilly & Co. (LLY) | 04-Feb-19 | Grant | 19,404 | $120.17 | $2,331,780.00 | 18% 105.28K to 124.68K | 36% |
05-Feb-19 6:55 PM View: | Eli Lilly & Co. (LLY) | 01-Feb-19 | Payment of Exercise | 3,995 | $119.86 | $478,841.00 | (4%) 109.27K to 105.28K | (36%) |
05-Feb-19 6:55 PM View: | Eli Lilly & Co. (LLY) | 01-Feb-19 | Option Exercise | 8,889 | -- | -- | 9% 100.38K to 109.27K | |
05-Feb-18 6:15 PM View: | Eli Lilly & Co. (LLY) | 01-Feb-18 | Payment of Exercise | 7,609 | $81.45 | $619,753.00 | (7%) 107.99K to 100.38K | (96%) |
05-Feb-18 6:15 PM View: | Eli Lilly & Co. (LLY) | 01-Feb-18 | Option Exercise | 17,060 | -- | -- | 19% 90.93K to 107.99K | |
31-Jan-18 6:00 PM View: | Eli Lilly & Co. (LLY) | 29-Jan-18 | Grant | 9,937 | $87.60 | $870,481.00 | 12% 80.99K to 90.93K | 82% |
05-Dec-17 5:46 PM View: | Eli Lilly & Co. (LLY) | 03-Dec-17 | Payment of Exercise | 3,567 | $85.32 | $304,336.00 | (4%) 86.67K to 83.1K | (87%) |
05-Dec-17 5:46 PM View: | Eli Lilly & Co. (LLY) | 03-Dec-17 | Option Exercise | 7,557 | -- | -- | 10% 79.11K to 86.67K | |
03-Feb-17 2:53 PM View: | Eli Lilly & Co. (LLY) | 01-Feb-17 | Payment of Exercise | 3,608 | $77.03 | $277,924.00 | (4%) 82.72K to 79.11K | (107%) |
03-Feb-17 2:53 PM View: | Eli Lilly & Co. (LLY) | 01-Feb-17 | Option Exercise | 7,683 | -- | -- | 10% 75.03K to 82.72K | |
31-Jan-17 5:57 PM View: | Eli Lilly & Co. (LLY) | 27-Jan-17 | Grant | 15,179 | $75.38 | $1,144,190.00 | 25% 59.85K to 75.03K | 112% |
08-Feb-16 3:43 PM View: | Eli Lilly & Co. (LLY) | 05-Feb-16 | Market Sale | 15,230 | $78.87 | $1,201,190.00 | (20%) 75.08K to 59.85K | (108%) |
03-Feb-16 1:50 PM View: | Eli Lilly & Co. (LLY) | 03-Feb-16 | Market Option Sale (Planned) | 725 | $76.46 | $55,433.50 | (< 1%) 75.8K to 75.08K | (114%) |
03-Feb-16 1:50 PM View: | Eli Lilly & Co. (LLY) | 01-Feb-16 | Payment of Exercise | 3,410 | $79.10 | $269,731.00 | (4%) 81.63K to 78.22K | (107%) |
03-Feb-16 1:50 PM View: | Eli Lilly & Co. (LLY) | 01-Feb-16 | Option Exercise | 7,252 | -- | -- | 10% 74.37K to 81.63K | |
03-Feb-16 1:50 PM View: | Eli Lilly & Co. (LLY) | 01-Feb-16 | Market Option Sale (Planned) | 2,412 | $78.39 | $189,077.00 | (3%) 78.22K to 75.8K | (109%) |
28-Jan-16 6:48 PM View: | Eli Lilly & Co. (LLY) | 26-Jan-16 | Grant | 14,525 | $81.96 | $1,190,470.00 | 24% 59.85K to 74.37K | 100% |
10-Mar-15 4:56 PM View: | Eli Lilly & Co. (LLY) | 09-Mar-15 | Market Sale | 4,000 | $69.27 | $277,080.00 | (6%) 63.85K to 59.85K | (141%) |
03-Feb-15 3:56 PM View: | Eli Lilly & Co. (LLY) | 01-Feb-15 | Payment of Exercise | 3,947 | $72.00 | $284,184.00 | (6%) 71.71K to 67.77K | (133%) |
03-Feb-15 3:56 PM View: | Eli Lilly & Co. (LLY) | 01-Feb-15 | Option Exercise | 8,394 | -- | -- | 13% 63.32K to 71.71K | |
30-Jan-15 5:18 PM View: | Eli Lilly & Co. (LLY) | 28-Jan-15 | Grant | 18,855 | $70.97 | $1,338,140.00 | 42% 44.46K to 63.32K | 137% |
28-Aug-14 2:06 PM View: | Eli Lilly & Co. (LLY) | 26-Aug-14 | Payment of Exercise | 7,809 | $62.73 | $489,859.00 | (15%) 52.27K to 44.46K | (170%) |
28-Aug-14 2:06 PM View: | Eli Lilly & Co. (LLY) | 26-Aug-14 | Option Exercise | 8,380 | $55.89 | $468,342.00 | 19% 43.89K to 52.27K | |
04-Feb-14 10:27 AM View: | Eli Lilly & Co. (LLY) | 01-Feb-14 | Payment of Exercise | 4,418 | $54.01 | $238,616.00 | (8%) 56.72K to 52.3K | (222%) |
04-Feb-14 10:27 AM View: | Eli Lilly & Co. (LLY) | 01-Feb-14 | Option Exercise | 9,405 | -- | -- | 20% 47.31K to 56.72K | |
30-Jan-14 8:30 PM View: | Eli Lilly & Co. (LLY) | 28-Jan-14 | Grant | 20,394 | $54.23 | $1,105,970.00 | 76% 26.92K to 47.31K | 220% |
29-Jan-13 4:44 PM View: | Eli Lilly & Co. (LLY) | 25-Jan-13 | Grant | 5,124 | $53.21 | $272,648.00 | 23% 22.02K to 27.14K | 239% |
05-Dec-12 1:30 PM View: | Eli Lilly & Co. (LLY) | 03-Dec-12 | Payment of Exercise | 1,166 | $49.04 | $57,180.60 | (5%) 23.19K to 22.02K | (267%) |
05-Dec-12 1:30 PM View: | Eli Lilly & Co. (LLY) | 03-Dec-12 | Option Exercise | 3,778 | -- | -- | 19% 19.41K to 23.19K | |
30-Jan-12 5:24 PM View: | Eli Lilly & Co. (LLY) | 26-Jan-12 | Grant | 5,962 | $39.44 | $235,141.00 | 46% 13.07K to 19.03K | 362% |